Private company

Danimer Scientific, Inc.

Danimer Scientific, Inc. is an American plastic materials company, incorporated in Delaware.1 It is headquartered in Bainbridge, Georgia.1

Last updated Oct 20, 2026.

Overview

  • IndustryPlastic Materials, Synth Resins & Nonvulcan Elastomers1
  • HeadquartersBainbridge, Georgia1
  • Incorporated inDE2
  • Business address140 Industrial Boulevard, Bainbridge, Ga 398172
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

The Company (formerly Live Oak Acquisition Corp.) was incorporated in Delaware on May 24, 2019 as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. Live Oak completed its initial public offering in May 2020. On December 29, 2020 (“Closing Date”), the Company consummated a business combination (“Business Combination”), pursuant to which the Company acquired all of the outstanding capital stock of Meredian Holdings Group, Inc., a Delaware corporation (“Meredian Holdings Group” or “MHG”) through the exchange of MHG common stock for Live Oak Class A common stock. The Business Combination was effected through the merger of Green Merger Corp., a wholly owned subsidiary of Live Oak, with and into MHG…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-269.1%Operating margin5
-333.0%Net margin5
-12.3%Revenue growth, 20235
-55.9%Return on equity5
1.50×Debt to equity5
-$74.9MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue43¢$73.6M
  • Research and development17¢$29.2M
  • Selling, general and admin40¢$69.0M
  • Income tax0¢$319.0K

Out of $46.7M in revenue.5 The company lost money this year.

Financial statements

Revenue675$46.7M in 2023+44% since 2019
0$20.0M$40.0M$60.0M2019: $32.3M$32.3M20192020: $47.3M$47.3M2020+46%2021: $58.7M$58.7M2021+24%2022: $53.2M$53.2M2022−9%2023: $46.7M$46.7M2023−12%
Operating income675-$125.6M in 2023+593% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$18.1M-$18.1M20192020: -$15.7M-$15.7M2020−13%2021: -$99.5M-$99.5M2021+532%2022: -$187.4M-$187.4M2022+88%2023: -$125.6M-$125.6M2023−33%
Net income675-$155.5M in 2023+697% since 2019
-$200.0M-$150.0M-$100.0M-$50.0M02019: -$19.5M-$19.5M20192020: -$8.9M-$8.9M2020−55%2021: -$60.1M-$60.1M2021+579%2022: -$179.8M-$179.8M2022+199%2023: -$155.5M-$155.5M2023−14%
Fiscal year201820192020202120222023
Revenue$32.3M6$47.3M6$58.7M7$53.2M5$46.7M5
Cost of revenue$21.2M6$35.9M6$57.9M7$63.6M5$73.6M5
Research and development$5.5M6$7.9M6$20.3M7$31.9M5$29.2M5
Selling, general and admin$16.0M6$19.3M6$80.0M7$81.6M5$69.0M5
Operating expenses$158.2M7$240.7M5$172.3M5
Operating income-$18.1M6-$15.7M6-$99.5M7-$187.4M5-$125.6M5
Interest$3.5M11$2.4M11
Income before tax-$73.3M7-$180.6M5-$155.2M5
Income tax$4.1M6$06-$13.2M7-$810.0K5$319.0K5
Net income-$19.5M6-$8.9M6-$60.1M7-$179.8M5-$155.5M5
Shares (weighted, basic)93.1M shares7101.1M shares5102.0M shares5
Shares (weighted, diluted)93.1M shares7101.1M shares5102.0M shares5

Compare Danimer Scientific, Inc. with another company

Corporate structure

Danimer Scientific, Inc. sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Danimer Scientific, Inc.

  • ARMISTICE CAPITAL, LLC Filed SCHEDULE 13G/A on Danimer Scientific, Inc., latest May 15, 2025 (3 filings since Nov 14, 2024)
  • VANGUARD GROUP INC Filed SC 13G/A on Danimer Scientific, Inc., latest Feb 9, 2023 (2 filings since Feb 9, 2022)
  • Invesco Filed SC 13G/A on Danimer Scientific, Inc., latest Feb 8, 2023 (2 filings since Feb 14, 2022)
  • Danimer Scientific, Inc. Bainbridge, Georgia
    • Danimer Bioplastics, Inc. Subsidiary · Georgia, United States
    • Danimer Scientific Holdings, LLC Subsidiary · Delaware, United States
    • Danimer Scientific Kentucky, Inc. Subsidiary · Delaware, United States
    • Danimer Scientific Manufacturing Inc. Subsidiary · Delaware, United States
    • Meredian Bioplastics, Inc. Subsidiary · Georgia, United States
    • Meredian Holdings Group, Inc. Subsidiary · Delaware, United States
    • Meredian, Inc. Subsidiary · Georgia, United States
    • Novomer, Inc. (f/k/a Sunshine Merger Corp.) Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Danimer Scientific, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Construction in progress$203.0M5 Dec 31, 2023$198.5M5 Dec 31, 2022+2.2%
Property and equipment, before depreciation$514.7M5 Dec 31, 2023$498.8M5 Dec 31, 2022+3.2%
Accumulated depreciation$69.6M5 Dec 31, 2023$44.9M5 Dec 31, 2022+55.0%
Property and equipment, net$445.2M5 Dec 31, 2023$453.9M5 Dec 31, 2022−1.9%
Operating-lease assets (leased space)$19.2M5 Dec 31, 2023$19.0M5 Dec 31, 2022+0.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$59.2M5 Dec 31, 2023$62.8M5 Dec 31, 2022−5.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$07 Dec 31, 2022$62.6M7 Dec 31, 2021−100.0%
Intangible assets, net (excluding goodwill)$77.8M5 Dec 31, 2023$80.9M5 Dec 31, 2022−3.9%
Accumulated amortization-$18.0M5 Dec 31, 2023-$13.3M5 Dec 31, 2022−34.6%
Finite-lived intangibles, net$75.0M5 Dec 31, 2022$83.8M6 Dec 31, 2021−10.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$25.3M5 Dec 31, 2023$32.7M5 Dec 31, 2022−22.8%
Raw materials$10.9M5 Dec 31, 2023$20.0M5 Dec 31, 2022−45.6%
Work in process$546.0K5 Dec 31, 2023$1.5M5 Dec 31, 2022−64.2%
Finished goods$13.9M5 Dec 31, 2023$11.3M5 Dec 31, 2022+23.1%

Leadership

Who has led Danimer Scientific, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Richard J. Hendrix2020
  2. Stephen Croskrey2020–2023
  3. Richard N. Altice2024

Chair

  1. Stephen Croskrey2020–2023

President

  1. Gary Kent Wunderlich Jr.2020

Chief financial officer

  1. Andrea K. Tarbox2020
  2. John Dowdy2020–2022
  3. Michael A. Hajost2022–2025

Chief operating officer

  1. Ross Berner2020
2025
Board members and other officers (15)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Danimer Bioplastics, Inc. Georgia3
  • Danimer Scientific Holdings, LLC Delaware3
  • Danimer Scientific Kentucky, Inc. Delaware3
  • Danimer Scientific L.L.C. Georgia3
  • Danimer Scientific Manufacturing Inc. Delaware3
  • Meredian Bioplastics, Inc. Georgia3
  • Meredian Holdings Group, Inc. Delaware3
  • Meredian, Inc. Georgia3
  • Novomer, Inc. (f/k/a Sunshine Merger Corp.) Delaware3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Live Oak Acquisition CorpJan 24, 2020 to Dec 28, 20202

Timeline

  1. Mar 18, 20258-K Bankruptcy or receivership; Debt or obligation accelerated; Other events33
  2. Feb 28, 20258-K Entered a material agreement34
  3. Feb 11, 20258-K Entered a material agreement; Debt or obligation accelerated35
  4. Dec 31, 20248-K Listing notice or transfer; Regulation FD disclosure36
  5. Dec 17, 20248-K Entered a material agreement; Ended a material agreement; New debt or obligation37
  6. Dec 13, 20248-K Executive or director change38
  7. Dec 12, 20248-K Executive or director change39
  8. Dec 3, 20248-K Executive or director change40
  9. Nov 19, 20248-K Results of operations41
  10. Nov 13, 20248-K Change to shareholders' rights; Bylaws or fiscal year changed42
  11. Oct 24, 20248-K Shareholder vote43
  12. Oct 16, 2024New chief executive Richard N. Altice becomes CEO12
  13. Oct 16, 20248-K Executive or director change44
  14. Dec 31, 2020New chief executive Stephen Croskrey becomes CEO14
  15. May 5, 2020New chief executive Richard J. Hendrix becomes CEO13

Filings

252 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 48 major events, 110 insider forms, 7 large holders, 74 other. The latest 20:

  1. May 15, 2025SCHEDULE 13G/A EDGAR
  2. Mar 18, 20258-K EDGAR
  3. Feb 28, 20258-K EDGAR
  4. Feb 14, 2025SCHEDULE 13G/A EDGAR
  5. Feb 11, 20258-K EDGAR
  6. Feb 10, 20254 EDGAR
  7. Jan 21, 20254 EDGAR
  8. Jan 3, 20254 EDGAR
  9. Dec 31, 2024424B3 EDGAR
  10. Dec 31, 20248-K EDGAR
  11. Dec 17, 2024424B3 EDGAR
  12. Dec 17, 20248-K EDGAR
  13. Dec 13, 2024424B3 EDGAR
  14. Dec 13, 20248-K EDGAR
  15. Dec 13, 2024424B3 EDGAR
  16. Dec 12, 20248-K EDGAR
  17. Dec 3, 2024424B3 EDGAR
  18. Dec 3, 20248-K EDGAR
  19. Nov 19, 2024424B3 EDGAR
  20. Nov 19, 202410-Q EDGAR

The 252 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

29 open-market trades by officers, directors and large owners since October 2021: 1 buys and 28 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 28, 2023HENDRIX RICHARD JDirectorBuy100,000$0.94$93.5KForm 4
Jun 20, 2023Tuten ScottChief Marketing OfficerSale10,000$2.74$27.4KForm 4
May 17, 2023Tuten ScottChief Marketing OfficerSale10,000$3.38$33.8KForm 4
Apr 17, 2023Tuten ScottChief Marketing OfficerSale10,000$4.26$42.6KForm 4
Mar 17, 2023Tuten ScottChief Marketing OfficerSale10,000$2.10$21.0KForm 4
Feb 17, 2023Tuten ScottChief Marketing OfficerSale10,000$2.21$22.1KForm 4
Jan 17, 2023Tuten ScottChief Marketing OfficerSale10,000$2.14$21.4KForm 4
Dec 19, 2022Tuten ScottChief Marketing OfficerSale10,000$1.63$16.3KForm 4
Nov 17, 2022Tuten ScottChief Marketing OfficerSale10,000$2.68$26.8KForm 4
Oct 17, 2022Tuten ScottChief Marketing OfficerSale10,000$2.46$24.6KForm 4
Sep 19, 2022Tuten ScottChief Marketing OfficerSale10,000$3.58$35.8KForm 4
Aug 19, 2022Pratt Stuart WDirectorSale100,000$4.77$477.0KForm 4
Aug 18, 2022Pratt Stuart WDirectorSale75,327$5.25$395.5KForm 4
Aug 17, 2022Tuten ScottChief Marketing OfficerSale10,000$5.06$50.6KForm 4
Jul 18, 2022Tuten ScottChief Marketing OfficerSale10,000$5.08$50.8KForm 4
Jun 17, 2022Tuten ScottChief Marketing OfficerSale10,000$3.79$37.9KForm 4
May 17, 2022Tuten ScottChief Marketing OfficerSale10,000$4.20$42.0KForm 4
Apr 18, 2022Tuten ScottChief Marketing OfficerSale10,000$5.03$50.3KForm 4
Mar 17, 2022Tuten ScottChief Marketing OfficerSale10,000$4.50$45.0KForm 4
Feb 17, 2022Tuten ScottChief Marketing OfficerSale10,000$4.05$40.5KForm 4

All 29 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Danimer Scientific, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARDanimer Scientific, Inc.1
  • CIK0001779020
  • Employer ID (EIN)84-19245181
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address140 Industrial Boulevard, Bainbridge, GA 398171
  • Phone229-243-70751
  • Shares outstanding120,795,476 as of Nov 12, 202410
  • Public float$243.0M as of Jun 30, 20235
  • On EDGAR sinceJan 24, 20201
  • Filings428 in all: 4 (146), 8-K (70), 424B3 (56), 3 (27), 10-Q (14), 425 (12), 4/A (8), CORRESP (8)1
    All 39 form types

    SC 13G (8), SC 13G/A (8), UPLOAD (8), DEF 14A (5), EFFECT (5), 10-K (4), 144 (4), DEFA14A (4), 25-NSE (3), 424B5 (3), S-1/A (3), S-4/A (3), 424B2 (2), 5 (2), 8-K/A (2), ARS (2), NT 10-Q (2), PRE 14A (2), S-1 (2), S-3 (2), S-8 (2), SCHEDULE 13G/A (2), 10-K/A (1), 424B4 (1), 8-A12B (1), 8-A12G (1), CERT (1), DRS (1), NT 10-K (1), S-4 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Mar 29, 2024
    Quarterly report (10-Q) Nov 19, 2024
    Proxy statement (DEF 14A) Sep 23, 2024
    Latest 8-K (8-K) Mar 18, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47